When psychedelics were first studied more than 50 years ago, researchers noticed that they were useful in helping people explore a greater sense of self. Now, after a half-century hiatus, scientists are studying psychedelics like MDMA, psilocybin, and ketamine as treatment for depression, PTSD, anxiety, and other mental health conditions. So, what promise do they hold as therapeutics? Albert Garcia-Romeu, a researcher at John’s Hopkins University, joins Dr. Sanjay Gupta to talk about how psychedelics can alleviate mental suffering and what the path forward might look like. This episode originally aired on November 8, 2022.
To learn more about how CNN protects listener privacy, visit cnn.com/privacy
Learn more about your ad choices. Visit podcastchoices.com/adchoices
Making Sense of Our World
Introducing All There Is with Anderson Cooper
Our Top Takeaways: Managing Social Anxiety
Chasing Life presents In the Bubble with Andy Slavitt
You’re Never Too Old to Play
Climate Anxiety is Real
Living in a Dream World
Learning to Live After Loss
The Video Game Treatment
How to Win the Waiting Game
Living to 100 and Beyond with Norman Lear
What Drives Your Road Rage?
Why Sanjay Almost Changed His Name to Steve
Conversation is More Than Nodding Your Head
Sometimes it's Healthy to Break the Rules
Go to the Beach, Doctor’s Orders
The Healing Power of Poop
Practicing Gratitude Pays Off
Bursting the Bath Time Bubble
Fighting That "Meh" Feeling
Create your
podcast in
minutes
It is Free
Good Mood Revolution
Newscast
Consider This from NPR
What’s That Rash?
The Coronavirus Podcast
Up First